Kabra Drugs Ltd Board Meeting Scheduled for April 21, 2026

Kabra Drugs Ltd Board Meeting Scheduled for April 21, 2026​

Kabra Drugs Ltd has scheduled a meeting of its Board of Directors for April 21, 2026, at the Company's Corporate Office in Chennai. The board has several key items listed for consideration and approval during this session.

The agenda for the board meeting includes matters concerning the appointment of a new director and strategic diversification of the company's operations.

During the meeting, the board will consider and approve the appointment of Ms. Monam Kapoor, holding DIN: 09278005, to serve as an Additional Director, designated as a Non-Executive and Independent Director of the Company.

Furthermore, the Board plans to discuss amendments to the Main Objects clause of the Memorandum of Association (MOA) to support business diversification. The proposed additions to the MOA include:

• Drones & Defence equipment manufacturing and distribution.
• Hospital, E-Pharmacy & Medical equipment manufacturing and distribution.
• All types of dairy products manufacturing.
• Intelligence (AI) technologies, Software & Hardware products manufacturing.
• Hospitality and allied service sectors.
• Establishing and running agro farms & manufacturing and trading of all kinds of agro products.

The board meeting agenda also covers the consideration and approval of the Notice of Postal Ballot for the aforementioned matters, as well as other related matters. Operational items scheduled for discussion include fixing the Cut-off date and E-voting schedule for the Postal Ballot process, and appointing a scrutinizer to ensure the entire Postal Ballot process remains fair and transparent.

The Company was managed by Nanjappan Aravind, Managing Director with DIN: 01895602.

Stock Price Movement​

As of 2:44 PM, Kabra Drugs Ltd shares are ticking down to ₹28.50, falling by 0.14%. Throughout the session, the stock navigated a range, moving between a low of ₹28.06 and a high of ₹29.34.

Source:​